Ravin Ratan, MD, M.Ed.

Peer-Reviewed Articles

1. Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. N Engl J Med 388(10):898-912, 2023. PMID: 36884323.
2. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2022. PMID: 36151848.
3. Moyers JT, Pestana RC, Roszik J, Hong DS, Naing A, Fu S, Piha-Paul S, Yap TA, Karp D, Rodon J, Livingston A, Zarzour MA, Ravi V, Patel S, Benjamin RS, Ludwig J, Herzog C, Ratan R, Somaiah N, Conley A, Gorlick R, Meric-Bernstam F, Subbiah V. Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102). Clin Cancer Res 29(2):401-409, 2023. e-Pub 2022. PMID: 36288393.
4. Hinchcliff E, Rumpf J, Ratan R, Fleming ND, Jazaeri A, Fellman B, Meyer L, Soliman P. Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma. Gynecol Oncol 167(3):490-495, 2022. e-Pub 2022. PMID: 36270831.
5. Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
6. Nathenson MJ, Hu J, Ratan R, Somaiah N, Hsu R, DeMaria PJ, Catoe HW, Pang A, Subhawong TK, Amini B, Sweet K, Feister K, Malik K, Jagannathan J, Braschi-Amirfarzan M, Sheren J, Caldas Y, Moreno Tellez C, Rosenberg AE, Lazar AJ, Maki RG, Benedetto P, Cohen J, Trent JC, Ravi V, Patel S, Wilky BA. Systemic chemotherapies retain anti-tumor activity in desmoid tumors independent of specific mutations in <em>CTNNB1 </em>or <em>APC</em>: A multi-institutional retrospective study. Clin Cancer Res 28(18):4092-4104, 2022. e-Pub 2022. PMID: 35180772.
7. Subbiah V, Braña I, Longhi A, Boni V, Delord JP, Awada A, Boudou-Rouquette P, Sarantopoulos J, Shapiro GI, Elias A, Ratan R, Fernandez C, Kahatt C, Cullell-Young M, Siguero M, Zeaiter A, Chawla SP. Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Relapsed Ewing Sarcoma: Results of a Basket Phase II Study. Clin Cancer Res 28(13):2762-2770, 2022. e-Pub 2022. PMID: 35486638.
8. Lamhamedi-Cherradi SE, Maitituoheti M, Menegaz BA, Krishnan S, Vetter AM, Camacho P, Wu CC, Beird HC, Porter RW, Ingram DR, Ramamoorthy V, Mohiuddin S, McCall D, Truong DD, Cuglievan B, Futreal PA, Velasco AR, Anvar NE, Utama B, Titus M, Lazar AJ, Wang WL, Rodriguez-Aguayo C, Ratan R, Livingston JA, Rai K, MacLeod AR, Daw NC, Hayes-Jordan A, Ludwig JA. The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma. Nat Commun 13(1):3057, 2022. e-Pub 2022. PMID: 35650195.
9. Boyce-Fappiano D, Damron EP, Farooqi A, Mitra D, Conley AP, Somaiah N, Araujo DM, Livingston JA, Ratan R, Keung EZ, Roland CL, Guadagnolo BA, Bishop AJ. Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions. Adv Radiat Oncol 7(3):100913, 2022. e-Pub 2022. PMID: 35647398.
10. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
11. Gounder MM, Merriam P, Ratan R, Patel SR, Chugh R, Villalobos VM, Thornton M, Van Tine BA, Abdelhamid AH, Whalen J, Yang J, Rajarethinam A, Duh MS, Bobbili PJ, Huynh L, Totev TI, Lax AK, Agarwal S, Demetri GD. Real-world Outcomes of Patients with Locally Advanced or Metastatic Epithelioid SArcoma. Cancer 127(8):1311-1317, 2021. e-Pub 2020. PMID: 33296083.
12. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat 186(3):871-882, 2021. e-Pub 2021. PMID: 33575859.
13. Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. "Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma.". Oncologist 26(3):250-260, 2021. e-Pub 2020. PMID: 33289298.
14. Gounder M, Schöffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, Attia S, Chugh R, Chen TW, Jahan T, Loggers ET, Gupta A, Italiano A, Demetri GD, Ratan R, Davis LE, Mir O, Dileo P, Van Tine BA, Pressey JG, Lingaraj T, Rajarethinam A, Sierra L, Agarwal S, Stacchiotti S. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol 21(11):1423-1432, 2020. e-Pub 2020. PMID: 33035459.
15. Tarek N, Said R, Andersen CR, Suki TS, Foglesong J, Herzog CE, Tannir NM, Patel S, Ratan R, Ludwig JA, Daw NC. Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. Cancers (Basel) 12(10), 2020. e-Pub 2020. PMID: 33050651.
16. Bishop AJ, Landry JP, Roland CL, Ratan R, Feig BW, Moon BS, Zarzour MA, Wang WL, Lazar AJ, Lewis VO, Torres KE, Guadagnolo BA. Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies. Cancer 126(14):3265-3273, 2020. e-Pub 2020. PMID: 32343846.
17. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma 2020:8363986, 2020. e-Pub 2020. PMID: 32565716.
18. Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL, Guadagnolo BA. Long-term outcomes for patients with desmoid fibromatosis treated with radiation therapy: a 10-year update and re-evaluation of the role of radiation therapy for younger patients. Int J Radiat Oncol Biol Phys 103(5):1167-1174, 2019. e-Pub 2018. PMID: 30552963.
19. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P, Wagner AJ, Anurova O, Collini P, Dei Tos AP, Flucke U, Hornick JL, Lobmaier I, Philippe T, Picci P, Ranchere D, Renne SL, Sbaraglia M, Thway K, Wagrodzki M, Wang WL, Yoshida A, Mariani L, Kawai A, Stacchiotti S. Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series. JAMA Oncol 4(9):e180219, 2018. e-Pub 2018. PMID: 29800950.
20. Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. Oncologist 22(10):1271-1277, 2017. e-Pub 2017. PMID: 28710342.
21. Goldberg JD, Zheng J, Ratan R, Small TN, Lai KC, Boulad F, Castro-Malaspina H, Giralt SA, Jakubowski AA, Kernan NA, O'Reilly RJ, Papadopoulos EB, Young JW, van den Brink MR, Heller G, Perales MA. Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant. Leuk Lymphoma 58(8):1-13, 2017. e-Pub 2017. PMID: 28073320.
22. Barba P, Ratan R, Cho C, Ceberio I, Hilden P, Devlin SM, Maloy MA, Barker JN, Castro-Malaspina H, Jakubowski AA, Koehne G, Papadopoulos EB, Ponce DM, Sauter C, Tamari R, van den Brink MRM, Young JW, O'Reilly RJ, Giralt SA, Perales MA. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34(+) Selected Grafts for Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 23(1):67-74, 2017. e-Pub 2016. PMID: 27789361.
23. Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, Buford AS, Fokt I, Skora S, Wang J, Naing A, Lazar AJ, Rohren EM, Daw NC, Subbiah V, Benjamin RS, Ratan R, Priebe W, Mikos AG, Amin HM, Ludwig JA. IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma. J Natl Cancer Inst 108(12), 2016. e-Pub 2016. PMID: 27576731.
24. Ratan, R. , Mason, A., Sinnot, B., Goldfarb, D., and Fleming, R.. Drosophila importin a1 performs paralog-specific functions essential for gametogenesis. Genetics(178):839-850, 2008.

Invited Articles

1. Ratan R, Roland CL, Bishop AJ. Desmoid Fibromatosis: Management in an Era of Increasing Options. Curr Oncol Rep 23(4):41, 2021. e-Pub 2021. PMID: 33719012.
2. Amin HM, Morani AC, Daw NC, Lamhamedi-Cherradi SE, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin RS, Patel S, Song J, Lazar AJ, Wang WL, Kurzrock R, Pappo A, Anderson PM, Schwartz GK, Araujo D, Cuglievan B, Ratan R, McCall D, Mohiuddin S, Livingston JA, Molina ER, Naing A, Ludwig JA. IGF-1R/mTOR targeted therapy for Ewing sarcoma: A meta-analysis of five IGF-1R-related trials matched to proteomic and radiologic predictive biomarkers. Cancers (Basel) 12(7):1768, 2020. e-Pub 2020. PMID: 32630797.
3. Bishop AJ, Ratan R, Roland CL. Evolutioni n the management of desmoid tumors: Challenging the role of upfront surgical resection. Bulletin of the American College of Surgeons 104(10), 2019.
4. Ratan R, Patel SR. Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?. Curr Treat Options Oncol 18(6):34, 2017. PMID: 28534249.
5. Ratan R, Patel SR. Chemotherapy for Soft Tissue Sarcoma. Cancer 122(19):2952-60, 2016. e-Pub 2016. PMID: 27434055.

Abstracts

1. Mark Agulink, William D. Tap, Gregory M. Cote, Ravin Ratan, Shaheer Khan, Sant P. Chawla, Steven Attia, Anothy D. Elias, Mohammed Milhem, Joseph Pressey, Amro Ali, Ingrid Mintautas, Riadh Lobbardi. Huan Liu, Eunju Hurh, Kathleen Neville, Brian Andrew Van Tine. A Phase 1 Study of CFT8634, A Novel Bifuctional Degradation Activating Compound (BIDAC) Degrader of BRD9, in Synovial Sarcoma and SMARCB1-NULL Tumors. CTOS Annual Meeting, 2023.
2. J Andrew Livingston, Jeffrey Cloutier, Anthony P. Conley, Richard Gorlick, Robert S. Benjamin, Kristi Posey, Elise Nassif, M. Alejandra Zarzour, Dejka Araujo, Ravin Ratan, Vinod Ravi, Neeta Somaiah, Heather Lin, Cheuk Hong Leung, Alexander J. Lazar, Valerea O. Lewis, Patrick Lin, Behrang Amini, Raul F. Valenzuela, Shreyaskumar Patel, Wei-Lien Wang. Chemotherapy and Prognostic Significance of Extent of Dedifferentiation in Dedifferentiated Parosteal Osteosarcoma. CTOS Annual Meeting, 2023.
3. Ryan A. Denu, MD, PhD, Cissimol P. Joseph, Elizabeth S. Urquiola, Precious S. Byrd, Ravin Ratan, MD, MEd, Maria Alejandra Zarzour, MD, Anthony P. Conley, MD, Dejka Araujo, MD, Vinod Ravi, MD, MS, MBA, Shreyaskumar Patel, MD, Wei-Lien Wang, MD, Alexander J. Lazar, MD, PhD, Neeta Somaiah, MD. Clinico-Genomic Analysis of KIT/PDGFRA/SDH Wild-Type Gatrointestinal Stromal Tumors Identifies Potential Driver Mutations. CTOS Annual Meeting, 2023.
4. Ryan A. Denu, Richard K. Yang, Alexander J. Lazar, Shalin Shreyaskumar Patel, Valerae Lewis, Jason Roszik, J. Andrew Livingston, Wei-Lien Wang, Kenna R. Shaw, Ravin Ratan, Maria Zarzour, Justin Byrd, Shaan M. Raza, Kadir C. Akdemir, Jordi Rodon Ahnert, Vivek Subbiah, Shreyaskumar Patel, Anthony Conley. Clinico-Genomic Profiling of Convetional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to be Associated With Worse Outcomes. CTOS Annual Meeting, 2023.
5. Madeline B. Torres, Cheuk Hong Leung, Emily Keung, Chun Feng, Hannah Beird, Alex Zarzour, Chris Scally, Kelly Hunt, Anthony Conley, Andrew Bishop, B. Ashleigh Guadagnolo, Ahsan Farooqi, Devarati Mitra, Dejka Araujo, Andrew Livingston, Ravin Ratan, Shreyaskumar Patel, Vinod Ravi, Alex Lazar, Christina L Roland, Neeta Somaiah, Elise F. Nassif. Dedifferentiated Liposarcomas Treated With Immune Checkpoint Blockade: The MD Anderson Experience. CTOS Annual Meeting, 2023.
6. Elise F. Nassif, Hannah Beird, Akash Mitra, Bin Liu, Kevin McBride, Wei-Lien Wang, Davis Ingram, Khalida Wani, Emily Z. Keung, Rare Tumor Initiative Team, Patient Mosaic Team, Alex Zarzour, Anthony Conley, Dejka Araujo, J. Andrew Livingston, Ravin Ratan, Shreyaskumar Patel, Vinod Ravi, Robert Benjamin, Alexander J. Lazar, Christina L. Roland, P. Andrew Futreal, Neeta Somaiah. Histology Specific Intratumoral B-Cell Biology in Alveolar Soft-Part Sarcomas (ASPS) in Response to Durvalumab-Tremelimumab (D-T). CTOS Annual Meeting, 2023.
7. Bernd Kasper, Mrinal Gounder, Ravin Ratan, Timothy Bell, Cristina Ivanescu, James Marcus, Allison Lim, Sandra Goble, Sunny Cho, Thierry Alcindor, Winette van der Graaf, Patrick Schoffski, Breelyn Wilky, Charlotte Benson, Nam Bui, Rashmi Chugh, Shivaani Kummar, Richard Riedel. Impact of Nirogacestat on Functional Status in Patients With Desmoid Tumors: Results From the Phase 3 DEFI Study. CTOS Annual Meeting, 2023.
8. Alicia Gingrich, Hannah Beird, Randy Chu, Ray Traweek, Brandon Cope, Emily Z. Keung, Chris P. Scally, Kelly K. Hunt, Keila E. Torres, Christina L. Roland, Sabitha PrabhakaranRare Tumor Initiative Team, Patient Mosaic Team, P. Andrewy Futreal, Andrew Bishop, B. Ashleigh Guadagnolo, Devarati Mitra, Ahsan Farooqi, Dejka Araujo, Alex M. Alejandra Zarzour, J. Andrewy Livingston, Anthony Conley, Shreyaskumar Patel, Vinod Ravi, Neetah Somaiah, Alexander J. Lazar, Ravin Ratan, Elise F Nassif. Leiomyosarcoma intratumoral macrophage infiltrates are associated with distinct clinical and genomic presentations. CTOS Annual Meeting, 2023.
9. Danh D. Truong, Emre Arsian, Veena Kochat, Sandhya Krishnan, Clement Nana Agyemang, Margarita Divenko, Davis R. Ingram, Rossana Lazcano Segura, Akshay Basi, Javier Gomez, Hannah Beird, Chia-Chin Wu, Jared Burks, P. Andrew Futreal, Alexander J. Lazar, Ravin Ratan, Najat C. Daw, Andrea Hayes-Dixon, Kunal Rai, Joseph A. Ludwig. Multi-Omic Analysis of Desmoplastic Small Round Cell Tumors Reveal Distinct Lineages. CTOS Annual Meeting, 2023.
10. Robin L. Jones, Mrinal Gounder, Rashmi Chugh, Mark Agulnik, Arun Singh, Brian Andrew Van Tine, Vladimir Andelkovic, Edwin Choy, Jeremy Lewin, Ravin Ratan, Howard A. Ball, Jonathan Y. Yovell, Gary Gordon, Andres Gutierrez, Bernd Kasper. Phase 2 Results From the Ringside Phase 2/3 Trial of AL102 for Treatment of Desmoid Tumors. CTOS Annual Meeting, 2023.
11. Rashmi Chugh, Sant P. Chawla, Alexander Spira, Vivek Subbiah, Lee Hartner, Breelyn Wilky, Nehal Lakhani, Christopher Lieu, Ravin Ratan, Brianne O'Neill, Vasily Andrianow, Emily C. Piccione, James Kalabus, Katelyn M. Willis, Brendan Eckelman, Patrick J. Grohar. The Tetravalent Death Receptor 5 Agonist INBRX-109 Combined With Chemotherapy in Ewing Sarcoma: Preliminary Data From a Phase 1 Study. CTOS Annual Meeting, 2023.
12. Jason Roszik, Ryan A. Denu, Elise F. Nassif, Michael S. Nakazawa, J. Andrew Livingston, Kadir C. Akdemir, Ravin Ratan, Alexander J. Lazar, Wei-Lien Wang, Roberto Pestana, Ahsan Farooqi, Christina Roland, Emily Z. Keung, Vinod Ravi, Neeta Somaiah, Shreyaskumar Patel, Anthony P. Conley,. TP53 Alterations in Sarcomas: An Analysis From the AACR-GENIE Database. CTOS Annual Meeting, 2023.
13. Emanuela Palmerini, Marco Gambarotti, Elizabeth A. Connolly, Steven G. Dubois, Salvatore Provenzano, Javier Martin-Broto, Antoine Italiano, Hanna Kosela-Paterczyk, Nadia Hindi, Ravin Ratan, Palma Dileo, Vivek A. Bhadri, Robin L. Jones, Lianne Haveman, Giovanni Grignani, Stefania Kokkali, Virginia Ferraresi, Christina Rothermundt, Antonia Digklia, Antonella Brunello, Juan Diaz-Martin, Daniela Katz, Silva Hofer, Angela M. Hong, Davide Donati, Angelo Paolo Dei Tos, Toni Ibrahim, Bruno Vincenzi, Silvia Stacchiotti. Ultra-Rare Undifferentiated Small Round Cell Sarcoma: How Should We Treat Them? An Analysis Form the Graceful Project. CTOS Annual Meeting, 2023.
14. Thierry Alcindor, Bernd Kasper, Mrinal M. Gounder, Ravin Ratan, Winette T.A. Van Der Graaf, Breelyn A. Wilky, Richard F. Riedel, Noah Federman, Agnese Peruzzi, Stephanie Moody, Allison Lim, Brad Tumminello, Shivaani Kummar, Patrick Schöffski. Tumor volume and T2 hyperintensity changes from DeFi: A phase 3, randomized, controlled trial of nirogacestat in patients with desmoid tumors. ASCO Annual Meeting, 2023.
15. Mrinal M. Gounder, Robin Lewis Jones, Rashmi Chugh, Mark Agulnik, Arun S. Singh, Brian Andrew Van Tine, Vladimir Andelkovic, Edwin Choy, Jeremy Howard Lewin, Ravin Ratan, Gary B. Gordon, Jonathan Yovell, Andres A. Gutierrez, Bernd Kasper. RINGSIDE phase 2/3 trial of AL102 for treatment of desmoid tumors (DT): Phase 2 results. ASCO Annual Meeting, 2023.
16. Prapassorn Thirasastr, Heather Y. Lin, Elise F Nassif, Wei-Lien Wang, Dejka M. Araujo, Robert S. Benjamin, Anthony Paul Conley, J Andrew Andrew Livingston, Joseph Aloysius Ludwig, Shreyaskumar Patel, Ravin Ratan, Vinod Ravi, Maria Alejandra Zarzour, Xiao Zhou, Neeta Somaiah. Clinical implications of recurring mutations in myxoid liposarcoma (MLS). ASCO Annual Meeting, 2023.
17. Winette T.A. Van Der Graaf, Mrinal M. Gounder, Ravin Ratan, Cristina Ivanescu, James Marcus, Timothy Bell, Allison Lim, L. Mary Smith, Ana Belen Oton, Thierry Alcindor, Patrick Schöffski, Breelyn A. Wilky, Richard F. Riedel, Charlotte Benson, Nam Bui, Rashmi Chugh, Shivaani Kummar, Bernd Kasper. Impact of nirogacestat on pain, a key symptom in patients with desmoid tumors (DT): Results from the phase 3 DeFi study. ASCO Annual Meeting, 2023.
18. Danh D. Truong, Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Hannah Beird, Chia-Chin Wu, Sandhya Krishnan, Davis R. Ingram, David McCall, Branko Cuglievan, P Andrew Futreal, Mark Titus, Alexander Lazar, Wei-Lien Wang, Kunal Rai, A Robert MacLeod, Ravin Ratan, J. Andrew Livingston, Najat C. Daw, Andrea Hayes-Jordan, Joseph A. Ludwig. The Epigenetic Impact and Therapeutic Opportunity of AR-Directed Therapy for DSRCT. CTOS Annual Meeting, 2022.
19. Mrinal M. Gounder, Ravin Ratan, Thierry Alcindor, Patrick Schöffski, Winette T.A van der Graaf, Breelyn A. Wilky, Richard F. Riedel, Allison Lim, L. Mary Smith, Stephanie Moody, Steven Attia, Sant P. Chawla, Gina D'Amato, Noah Federman, Priscilla Merriam, Brian A. Van Tine, Bruno Vincenzi, Shivaani Kummar, Bernd Kasper. A Phase 3, Randomized Double-Blind Trial of Nirogacestat versus placebo for Progressing Desmoid Tumors/Aggressive Fibromatosis. CTOS Annual Meeting, 2022.
20. Jonathan Gill, Anthony P. Conley, Neeta Somaiah, Dejka M. Araujo, Ravin Ratan, Kristi Posey, Robert S. Benjamin, Shreyaskumar Patel, Najat C. Daw, Douglas J. Harrison, Richard Gorlick, Heather Lin, Wei-Lien Wang, Behrang Amini, Nancy Gordon, J. Andrew Livingston. A Phase 1/2 Trial of Gemcitabine, Docetaxel, and Hydroxychloroquine in Advanced / Metastatic Osteosarcoma: Results of Phase 1. CTOS Annual Meeting, 2022.
21. Lee D. Cranmer, Albiruni Ryan Abdul Razak, Ravin Ratan, Edwin Choy, Suzanne George, David A. Liebner, David D. Stenehjem, Mrinal M. Gounder. Results of a phase I dose escalation and expansion study of tegavivint (BC2059), a first-in-class TBL1 inhibitor for patients with progressive, unresectable desmoid tumor. ASCO Annual Meeting, 2022.
22. Prapassorn Thirasastr, Cissimol Joseph, Dejka M. Araujo, Robert S. Benjamin, Anthony Paul Conley, J Andrew Andrew Livingston, Joseph Aloysius Ludwig, Shreyaskumar Patel, Ravin Ratan, Vinod Ravi, Maria Alejandra Zarzour, Xiao Zhou, Neeta Somaiah. Outcomes in late-line systemic treatment in GISTs: Does sequence matter?. ASCO Annual Meeting, 2022.
23. Michael Nakazawa, J Andrew Andrew Livingston, Andrew Justin Bishop, Maria Alejandra Zarzour, Neeta Somaiah, Ravin Ratan, Jonathan Benjamin Gill, Elizabeth Urquiola, Kristi Posey, Beverly Ashleigh Guadagnolo, Richard Greg Gorlick, Robert S. Benjamin, Shreyaskumar Patel, Anthony Paul Conley. Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma (ARMS) patients on front-line therapies: An MD Anderson Cancer Center (MDACC) case series. ASCO Annual Meeting, 2022.
24. Neeta Somaiah, J Andrew Andrew Livingston, Vinod Ravi, Heather Y. Lin, Behrang Amini, Luisa Maren Solis, Anthony Paul Conley, Maria Alejandra Zarzour, Joseph Aloysius Ludwig, Ravin Ratan, Wei-Lien Wang, Dejka M. Araujo, Shreyaskumar Patel, Christina Lynn Roland, Alexander J. Lazar, Richard Greg Gorlick, Edwin R. Parra, Cara L. Haymaker. A phase II multi-arm study to test the efficacy of oleclumab and durvalumab in specific sarcoma subtypes. ASCO Annual Meeting, 2022.
25. Emily Zhi-Yun Keung, Elise F Nassif, Heather Y. Lin, Alexander J. Lazar, Keila E Torres, Wei-Lien Wang, Beverly Ashleigh Guadagnolo, Andrew Justin Bishop, Kelly Hunt, Barry W. Feig, Justin E. Bird, Valerae O. Lewis, Ravin Ratan, Shreyaskumar Patel, Monika Zelazowska, Bin Liu, Kevin McBride, Jennifer Ann Wargo, Christina Lynn Roland, Neeta Somaiah. Randomized phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS): Survival results after 2 years of follow-up and intratumoral B-cell receptor (BCR) correlates. ASCO Annual Meeting, 2022.
26. Joseph Aloysius Ludwig, Noah C. Federman, Peter Meade Anderson, Margaret E Macy, Richard F. Riedel, Lara E. Davis, Najat C. Daw, Jade Wulff, AeRang Kim, Ravin Ratan, Edwina S Baskin-Bey, Jeffrey A. Toretsky, James Bradley Breitmeyer, Paul A. Meyers. TK216 for relapsed/refractory Ewing sarcoma: Interim phase 1/2 results. ASCO Annual Meeting, 2021.
27. J.A. Ludwig, N. Federman, P. Anderson, M.E. Macy, L.E. Davis, R.F. Riedel, J.A. Muscal7, N.C. Daw, R. Ratan, J. Toretsky, X. Ianopulos, F.J. Hsu, J.B. Breitmeyer, P. Meyers. Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma. ESMO Annual Meeting, 2020.
28. Gounder MM, Stachiotti S, Schoffski P, Cote GM, Villalobos VM, Jahan MJ, Chen TW, Ratan R, Gupta AA, Dileo P, Agulnik M, Italiano A, Attia S, Mir O, Pressey JG, Sierra L, Lingaraj T, Yang J, Agarwal S, Jones RL. Efficacy, safety, and immune priming effect of tazemetostat in patients with epithelioid sarcoma. J Clin Oncol 38(suppl), 2020.
29. Somaiah N, Conley AP, Lin HY, Amini B, Sabir S, Araujo DM, Benjamin RS, Livingston JA, Patel S, Ratan R, Ravi V, Zarzour MA, Wang WL, Tate T, Roland CL, Daw NC, Futreal A, Lazar AJ, Wistuba II, Hwu P. A phase II multi-arm study of durvalumab and tremilimumab for advanced or metastatic sarcomas. J Clin Oncol 38(suppl), 2020.
30. Roland CL, Keung EZ, Lazar AJ, Torres KE, Wang WL, Guadagnolo A, Bishop AJ, Lin HY, Feig BW, Bird JE, Lewis VO, Tawbi HA, Ratan R, Patel S, Wargo JA, Somaiah N. Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS). J Clin Oncol 38(suppl), 2020.
31. Hinchcliff E, Rumpf J, Ratan R, Fleming ND, Jazaeri AA, Pitcher P, Soliman PT. Present-day management of uterine leiomyosarcoma: Evaluation and treatment sequencing and other prognostic factors. J Clin Oncol 38(suppl), 2020.
32. Subramaniam A, Zheng J, Yalamanchili S, Conley AP, Ratan R, Somaiah N, Livingston JA, Zarzour MA, Araujo DM, Benjamin RS, Patel S, Ravi V. Modulation of YAP/TAZ by statins to improve survival in epithelioid hemangioendothelioma (EHE). J Clin Oncol 38, 2020.
33. Gounder M, Schoffski P, Stachiotti S, Villalobos V, Chugh R, Agulnik M, Attia S, Chen TW, Gupta A, Jahan T, Jones R, Italiano A, Blay JY, Cote JM, Demetri G, Loggers E, Ratan R, Fouladi M, Macy M, Makin G, Clawson A, Daigle S, Mencio C, Sapir I, Bourdeat F.. EZH2 inhibitor tazemetostat (taz) interim data in in adults and pediatric patients with INI-1 negative soft-tissue sarcomas (STS) including epithelioid sarcoma (ES). CTOS Annual Meeting, 2018.
34. Stacchiotti, S, Blay JY, Jones RL, Demetri G, Italiano A, Thomas D, Chen TW, Schoffski P, Gil T, Jahan T, Cote G, Ratan R, Attia S, Roche M, Daigle S, Sapir I, Clawson A, Gounder M. A phase II, multicenter study of the EZH2 inhbitor tazemetostat in adults (INI-1 negative tumors cohort)(NCT02601950). Annals of Oncology 29(suppl_8), 2018.
35. Parkes AM, Patel S, Leung CH, Lin HY, Conley AP, Somaiah N, Araujo DM, Zarzour MA, Livinston JA, Ludwig J, Ravi V, Benjamin R, Ratan R. Systemic therapy regimen outcomes in metastatic phyllodes tumor of the breast. ASCO Annual Meeting suppl, 2018.
36. Subbiah V, Sankala KK, Ratan R, Garcia ES, Valentina B, Gil T, Villalobos V, Chawla S, Lardelli P, Siguero M, Kahatt CM, Sotos-Matos A, Ferrari S. Efficacy and Safety of Lurbinectedin (PM1183) in Ewing Sarcoma: Final Results from a phase 2 study. J Clin Oncol 36(suppl), 2018.
37. Ratan R, Livingston JA, Wang W, Zarzour MA, Patel SR. CIC rearranged sarcomas: The MD Anderson experience with a rare, recently recognized entity. CTOS Annual Meeting, 2017.
38. Frezza AM, Asano N, Jones R, Ratan R, Teterycz P, Gelderblom H, Boye K, Brahmi M, Palmerini E, Hindi N, Brunello A, Desar I, Grignani G, Fedenko AA, Vicenzi B, Papai Z, Kawai A, Lo Vullo S, Casali PG, Stachiotti S. Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: Results of a retrospective multi-insitutional case series. J Clin Oncol 35(suppl), 2017.
39. Conley AP, Huh WW, Roszik J, Harrison DJ, Hayes-Jordan AA, Kehr KA, Ratan R, Somaiah N, Ravi V, Araujo DM, Zarzour MA, Ludwig JA, Wang WL, Benjamin RS, Patel S. Clinical characteristics of adult alveolar rhabdomyosarcoma (ARMS) patients (Pts) on front-line therapies: An MD Anderson Cancer Center (MDACC) series. J Clin Oncol 34(suppl), 2017.
40. Anthony Paul Conley, Winston W. Huh, Jason Roszik, Douglas James Harrison, Andrea Anita Hayes-Jordan, Kathleen A Kehr, Ravin Ratan, Neeta Somaiah, Vinod Ravi, Dejka M. Araujo, Maria Alejandra Zarzour, Joseph A. Ludwig, Wei-Lien Wang, Robert S. Benjamin, Shreyaskumar Patel. Clinical characteristics of adult alveolar rhabdomyosarcoma (ARMS) patients (Pts) on front-line therapies: An MD Anderson Cancer Center (MDACC) series. ASCO Annual Meeting, 2016.
41. Nathenson MA, Conley AP, Ratan R, Zarzour MA, Somaiah N, Araujo DM, Patel S, Benjamin RS, Ravi V. Efficacy of front-line chemotherapy for recurrent/metastatic adenosarcoma of the uterus. J Clin Oncol 34(suppl), 2016. e-Pub 2016.

Book Chapters

1. Ratan R, Benjamin RS. Sarcomas of the Skull Base. In: Comprehensive Management of Skull Base Tumors. 2nd. Thieme: New York, 2021.
2. Ratan R, Patel SR. Medical Oncology. In: Sarcomas: Evidence-Based Diagnosis and Management. 1. Springer, 2020.
3. Ratan R, Ater J, Reiber AG, Rodriguez MA. Long-term survivorship in Adult and Pediatric Cancer. In: In: MD Anderson Manual of Medical Oncology. 3, 2016.